David Hatt is currently the Director of Quality Audits for Teva Pharmaceuticals, a position that I have held since September 2013. In this position David oversees Teva’s external supplier audit program for GxP goods and services for the Americas region, and assist with risk mitigation as Quality & Compliance issues arise from these external suppliers around the globe. David also provides quality support in strategic sourcing of new molecules. Prior to this role, David acted as the direct liaison between Teva Canada and regulatory agencies (including FDA and Health Canada) and was responsible for all internal and external auditing, and quality knowledge management at the three Teva Canada sites (in the Toronto area). David has held various quality roles at Teva, where he started over 20 years ago as a research chemist in the lab. David has a Bachelor of Science from the University of Guelph, with a major in Biochemistry and a minor in Biomedical Sciences.